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ABSTRACT
This is the protocol for a review and there is no abstract. The objectives are as follows:
The main objective of this review is to assess the effects of laminectomy and fusion versus laminoplasty for multilevel cervical stenosis
with myelopathy, on treatment outcomes such as pain, quality of life, functional and neurological improvement, and complication
rates.

BACKGROUND

Description of the condition
Cervical myelopathy is a clinical condition of spinal cord dysfunction which demonstrates characteristic findings of upper motor
neuron syndrome, also referred to as central motor neuron disease.
One of the initial symptoms of myelopathy often involves loss of
finger dexterity in the upper extremities. Patients usually report
progressive loss of function including difficulty with fine movements in ordinary activities such as buttoning buttons and handwriting. Some patients also present with lower limb spasticity and
a resultant wide based, shuffling gait. Ultimately, this ataxia may
become so severe that patients become wheelchair dependent. In

addition to ataxia, the lower limbs often demonstrate hyperreflexia
and pathologic reflexes. These pathologic reflexes result from a
pathway defect between peripheral nerves and the brain modulation, including Hoffmann’s (thumb and index finger interphalangeal joints flex when distal phalanx of third finger is flicked),
Babinsky’s (extensor plantar reflex) and Openheimer’s (dorsiflexion of the hallux elicited by stimulation of middle third of tibia)
reflexes (Clarke 1956; Payne 1957; Tracy 2010; Veidlinger 1981).
The most common cause of cervical myelopathy is degenerative
changes resulting in acquired stenosis. Cervical stenosis is a radiographic diagnosis based on the narrowing of the spinal canal, possibly leading to spinal cord compression and the clinical syndrome
of cervical spondylotic myelopathy. The normal spinal canal diameter is 15 to 17mm, depending on measurement techniques and
population. Patients with a cervical canal under 13mm of anterior
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to posterior diameter are considered to have stenosis (Chazono
2012; Edwards 1983) and progression of cervical myelopathy has
been observed to occur in patients with midsagittal diameter less
than 12mm (Boden 1990). Axial sections demonstrating an area
below 40mm2 and compression ratio (relation between sagittal and
transverse diameter) beneath 40% are also less favourable prognostic factors (Law 1993; Veidlinger 1981).
Degenerative changes, including hypertrophy of facet and uncovertebral joints (cartilage interface that connects adjacent vertebral bodies), osteophytosis (bone spurs), disc herniation, thickening of ligamentum flavum (ligaments that surround the posterior aspect of spinal cord) and ossification of posterior longitudinal ligament (structure related to anterior aspect of spinal cord),
are the predominant structural changes that cause cervical stenosis
(Bernhardt 1993; Edwards 2003).
Cervical spondylotic myelopathy can be classified by the syndromes it produces, divided into five categories:
1. Transverse lesion syndrome, where all spinal tracts are
equally affected;
2. Motor system syndrome, where motor spinal tracts are
involved, resulting in spasticity and loss of strength;
3. Central cord syndrome, where upper extremities are more
severely affected than lower in sensory and motor aspects;
4. Brown-Séquard syndrome, where a patient presents
ipsilateral motor deficits with contralateral sensory deficits; and
5. Braquialgia, where there is motor or sensory impairment in
the upper extremity (Crandall 1966).
Cervical myelopathy also can be defined by the site in which compression occurs, separated into four syndromes:
1. Medial syndrome, with impairment primarily of long tract
signs;
2. Lateral syndrome, characterized by radicular lesion;
3. Medial and lateral syndromes combined; and
4. Vascular syndrome, characterized by quickly progressive
myelopathy signs due to vascular insufficiency (Ferguson 1985)

mity. The most commonly performed fusion method is arthrodesis of the facet joints and lateral masses with lateral mass and pedicle screws. Nevertheless some spine surgeons choose not to use
arthrodesis, but rather release the spinal cord using laminectomy
alone or the skip laminectomy (a variation of classical laminectomy
with less bone removed) (Heller 2001; Manzano 2012; Shiraishi
2003).
Cervical laminoplasty is a canal-expanding procedure to preserve
motion in the cervical spine. Hirabayashi described the expansive open-door laminoplasty procedure in the late 1970s. The key
principle of this procedure is to minimize disruption of the posterior structures of cervical spine including ligaments and muscular
insertions, keeping them relatively preserved. By using a drill on
both sides of the posterior vertebra, both the internal and external
cortex of the lamina on one side is cut while only the external
cortex is cut on the opposite site, and then the lamina is opened
like a door (Hirabayashi 1978; Hirabayashi 1983).
A variation of Hirabayashi technique is called French-door or double-door laminoplasty (Kaneyama 2010; Kurokawa 1982; Okada
2009). This procedure is performed by making a cut in the centre
of the spinal process and the external cortex on both sides of the
lamina. Some surgeons use suture wire or bone grafts to keep the
lamina or spinous process open. However, there are other options
to maintain the decompression, such as small plates, anchors or
similar devices (Lee 2007; Mitsunaga 2012).

How the intervention might work
Decompression of cervical spinal stenosis using a posterior approach, such as laminectomy or laminoplasty techniques, increases
the space in the cervical canal. These procedures decompress
the spinal cord directly by removing compressive posterior structures, and/or indirectly by increasing the transverse diameter of
the cervical canal when compression is due to anterior structures
(Herkowitz 2011).

Description of the intervention
Posterior surgical decompression procedures for cervical myelopathy are often used in patients with three or more levels involved. The most commonly performed approaches are laminectomy alone, laminectomy with arthrodesis, and laminoplasty
(Highsmith 2011; Lee 2007; Manzano 2012).
Cervical laminectomy is the oldest procedure described for decompression of the cervical spinal cord. It has been applied since the
early 1900s. It consists of removing posterior elements of the spinal
canal including the lamina, spinal processes, interspinous and
supraspinous ligaments, ligamentum flavum, and sometimes, portions of the articular facets (Jenkins 1973; Nurick 1972; Veidlinger
1981).
Cervical laminectomy is commonly performed along with fusion
to prevent the development of post laminectomy kyphotic defor-

Why it is important to do this review
Myelopathy secondary to spondylotic cervical canal stenosis is currently the most common cause of cervical spinal disease observed
in patients over 55 years. The natural history of untreated cervical
myelopathy is stepwise progression towards severe disability. As
such, surgical decompression with or without fusion is the treatment of choice for patients with symptomatic cervical myelopathy
(Bernhardt 1993; Edwards 2003; Fehlings 2013a; Fehlings 2013b;
Lees 1963; Sampath 2000).
Posterior approaches such as laminectomy with bone fusion and
laminoplasty are techniques most applied in patients with three
or more compressive levels without kyphotic deformity. Laminectomy, as previously described, consists of removing vertebral lamina, spinal process, and ligaments to promote a wide decompres-

Posterior surgical approach procedures for cervical myelopathy (Protocol)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

2

sion. After decompression a rigid cervical fusion is performed with
rods and screws. Laminoplasty also increases the cervical canal diameter but with less anatomical disruption. Additionally, cervical
fusion is not performed. Since the spine is not fused and anatomical structures are preserved, it is argued that cervical spines after
laminoplasty will maintain a greater range of motion when compared to cervical spines after laminectomy and fusion. Despite
this theoretical advantage, clinically detectable differences between
these two treatments have yet to be demonstrated (Bartels 2007;
Hirabayashi 1983; Kaneyama 2010; Koakutsu 2010; Manzano
2012; Okada 2009; Shiraishi 2003; Woods 2011; Yukawa 2007).
The best surgical option for treating patients with multilevel cervical myelopathy remains a subject of great controversy. A recent
survey of North American spine surgeons evaluated the most common surgical treatments employed for multilevel cervical spinal
stenosis (three or more compressed levels), without kyphotic deformity, and with myelopathic symptoms. Findings indicate that
laminectomy with fusion is the procedure of choice for 70% of
surgeons, laminoplasty for 23%, and that just 7% of respondents
chose laminectomy without fusion to treat this specific patient
population (Manzano 2012).
One of the major concerns of spine surgeons who perform multilevel cervical decompression is the development of postoperative
cervical kyphosis (forward curvature). Cervical kyphosis may lead
to a deterioration in neurological state due to compression of the
spinal cord over the ventral kyphotic deformity. The normal cervical alignment averages 14.4o of lordosis (Albert 1998).
Cervical laminectomy without fusion has an incidence of postoperative kyphosis ranging from 14% to 47% (Anderson 2009; Kato
1998; Ryken 2009; van Geest 2013). Rates of deterioration of neurological state associated with development of kyphosis can vary
between 10% and 39% (Arnold 1993; Ebersold 1995; McAllister
2012; Yonenobu 1986). It is still uncertain to what extent cervical spine instability with consequent kyphosis contributes to late
neurological deterioration. These data may explain why cervical
laminectomy without fusion is no longer a popular procedure.
Laminectomy with fusion and laminoplasty seem to be the most
commonly chosen procedures by spine surgeons due to safety and
ethical concerns. This Cochrane systematic review will be conducted in order to identify randomized trials, quasi-randomized
trials and non-randomized studies evaluating each procedure, and
to clarify which is most beneficial to patients with cervical stenosis.
In conclusion, since cervical myelopathy affects a considerable portion of the population and due to the lack of consensus regarding
treatment, this review will help to elucidate the clinical nuances of
the most commonly performed posterior approach procedures in
order to achieve wide cervical decompression. If successful, this review can change the perspective of treatment of cervical myelopathy, increase patients’ quality of life, and optimize costs, providing evidence-based data in order to assist spine surgeons to treat
multilevel cervical myelopathy worldwide.

OBJECTIVES
The main objective of this review is to assess the effects of laminectomy and fusion versus laminoplasty for multilevel cervical stenosis with myelopathy, on treatment outcomes such as pain, quality
of life, functional and neurological improvement, and complication rates.

METHODS

Criteria for considering studies for this review

Types of studies
We will include randomized controlled trials (RCTs) in this review.
Moreover, since the preliminary search showed few RCTs on this
topic, we will also include quasi-randomized controlled trials (qRCTs) (i.e., non-random method of allocation such as hospital
record number, date of care) as well as prospective observational
studies with a control group, referred to here as non-randomized
studies (NRSs).

Types of participants
Participants in included studies must meet the following criteria:
1. Older than 18 years;
2. Presence of symptomatic cervical myelopathy secondary to
multilevel cervical canal stenosis (three or more levels of
impairment);
3. Associated spondylosis, disc herniation, or ossification of
the posterior longitudinal ligament (OPLL);
4. Magnetic resonance imaging (MRI) of cervical spinal cord
compression.
We will exclude studies involving participants who present with
the following:
1. Any degree of kyphotic deformity on cervical spine;
2. Previous surgical intervention.

Types of interventions
We will include studies that compare laminectomy with fusion to
laminoplasty, as these are the most commonly applied posterior
approach procedures (Manzano 2012) for patients with multilevel
cervical stenosis.
We will also compare different laminoplasty surgeries such as single-door or double-door techniques as a secondary goal.
Studies that compare laminectomy without fusion to other interventions will be excluded.
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Types of outcome measures
Primary and secondary outcomes may be measured at different
time points. We define short-term follow-up as closest to four
weeks and long-term follow-up as closest to one year (Furlan
2009). Outcomes related to neurological function, quality of life,
pain, range of motion and reoperation rates may be measured at
short-term and/or long-term follow-up. However we believe that
long-term measurements will provide better indications of the patient’s status after treatment, with the exception of nerve root palsy
(usually a transitory symptom, C5 is the most commonly affected
root), which is an important short-term outcome. Besides primary
and secondary outcomes, major (e.g. mortality, irreversible paralysis, deep infection) and minor (e.g. superficial wound infection,
dysphagia) adverse events also will be evaluated and included in
the Discussion (Fehlings 2012).

Primary outcomes

• Measurements of neurological function based on a
validated specific cervical scale:
◦ Japanese Orthopaedic Association (JOA) Scale (JOA
1976; JOA 1994)
◦ Modified Japanese Orthopaedic Association (mJOA)
Scale (Benzel 1991; Chiles 1999)
◦ Neck Disability Index (Vernon 1991)
◦ Nurick Scale (Nurick 1972)
• Health related quality of life analysis will be measured
through validated quality of life scales (e.g. Short-Form 36, JOA
Cervical Myelopathy Evaluation Questionnaire/JOACEMQ,
EuroQol) (Ware 1992, Nikaido 2009, EuroQol 1990)
• Pain (visual analogue scale) (Revill 1976)
• Cervical range of motion
• Kyphosis incidence (the cervical sagittal alignment has been
demonstrated to be an important outcome in spine surgery
procedures. Previous studies demonstrated that laminectomy as
well as laminoplasty techniques can be followed by the
development of kyphotic deformity, a situation that can lead
ultimately to an important deterioration of neurological status)

Secondary outcomes

• Nerve root palsy and recovery rates (most commonly
affected is C5 nerve root)
• Reoperation rates

1. Cochrane Central Register of Controlled Trials
(CENTRAL; The Cochrane Library)
2. Cochrane Back Group Trials Register (through CENTRAL,
and through the Cochrane Register of Studies (CRS), for studies
not in CENTRAL)
3. MEDLINE (OvidSP) and MEDLINE Non-Indexed and
In-Process Citations (OvidSP)
4. EMBASE (OvidSP)
5. PubMed, for studies not in MEDLINE
6. Latin-American and Caribbean Center on Health Sciencies
Information (LILACS)
No restrictions as to language or date of publication will be applied,
and all databases will be searched from the date of their inception
to present. We will use the search methods recommended by
Furlan 2009 and Higgins 2011 and the strategies developed by
the Cochrane Back Review Group (CBRG). A draft strategy for
MEDLINE can be found in Appendix 1. It will be translated as
closely as possible across the other databases.
We will also search the following trial registries for ongoing studies:
1. WHO International Clinical Trials Registry Platform (
WHO ICTRP)
2. United States National Institute of Health registry of
clinical trials (ClinicalTrials.gov)
3. Biomed Central’s Database of Current Controlled Trials (
ISRCTN registry)
Searching other resources
Personal communication with experts in this field.
We will also check reference lists of relevant review articles and
trials.

Data collection and analysis

Selection of studies
Two authors (PHIP and TY) will analyse studies identified in
the search. These authors will independently apply the inclusion
criteria to select the potentially relevant studies by screening titles
and abstracts as well as full texts. In case of disagreement, they
will consult a third author (MJST) who will evaluate the full texts
only.
Data extraction and management

Search methods for identification of studies

Electronic searches
We will search the following databases:

All relevant data will be extracted independently by two authors
(PHIP and MJST) and entered into a data sheet, in pairs, including information such as trial authors, affiliation, conflicts of interest, study design, number of patients, population characteristics,
brief description of surgical techniques, follow-up periods, complications, reoperation data, outcome data, and a brief summary
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of risk of bias. The authors will enter all data into Review Manager
5.3 (RevMan 2014).

Unit of analysis issues

Assessment of risk of bias in included studies

Dealing with missing data

Two authors, PHIP and MJST, will evaluate each study independently. Included studies will be assessed using the ’Risk of bias’
criteria recommended by the CBRG (Furlan 2009; Higgins 2011)
associated with items from the Downs and Black checklist (Downs
1998). In cases of disagreement, a third author (LMRR) will be
consulted. These criteria are allocated into five bias categories,
namely selection bias, performance bias, attrition bias, detection
bias and selective outcome reporting, with a total of 13 distinct
items (Appendix 2).
We will evaluate the studies according the criteria mentioned above
where each item will be scored according to its characteristics as
’high’, ’low’ or ’unclear’ and reported in the ’Risk of bias’ table.
If one or more criteria are rated as ’unclear’, we will contact the
study authors for additional information. The overall risk of bias
of each one of the five bias categories will be rated as ’bias’ or ’no
bias’.
For grading the evidence quality we will assess studies as follows:
the evidence level from studies that we qualified as ’no bias’ for all
five bias categories will not be downgraded. For studies that have
three or fewer categories qualified as having ’bias’, evidence will be
downgraded by -1 point. Studies that have four or five categories
qualified as having ’bias’ will be downgraded by -2 points.
We are aware of several potential confounders when examining
treatment effects in this area. Some of them include age (patients
less than 60 years old at the time of surgery have better neurological recovery), cervical curvature magnitude (normal preoperative
cervical lordosis can be responsible for better outcome results),
symptom duration (patients with longer symptomatology tend to
have worse recovery), transverse area of spinal cord on MRI, etiology of cervical spinal stenosis (different populations susceptible to
cervical spondylosis versus OPLL may have different outcomes),
and differences related to follow-up outcome forms (Kohno 1997;
Morio 2001; Naderi 1998; Tetreault 2013; Yamazaki 2003).

In studies where relevant data are missing, we will contact the
authors of trials for additional information. Studies that have more
than 20% of data missing will be subject to a sensitivity analysis
to evaluate the impact of excluding these data from the analysis.

Measures of treatment effect
We will calculate risk ratios (RRs) with a 95% confidence interval for dichotomous outcomes. However, for outcomes which
are measured using different scales, we will report a standardized
mean difference (SMD). For continuous outcomes we will calculate mean differences (MDs) comparing different studies with
different weights according to the standard deviation (SD) also
using a 95% confidence interval. When more than two interventions are present in same study, we will calculate a single ’pairwise’ comparison to avoid ’double-counting’ of patients.

The data of patients reported in included studies will be used as
the unit of analysis.

Assessment of heterogeneity
The I2 statistic and Chi2 test will be used to assess the clinically
homogenous studies, while heterogenousstudies will be evaluated
qualitatively. Then the review team will use clinical judgment to
examine the potential sources of heterogeneity, such as differences
in interventions, characteristics of participants, interventions, controls groups, and outcomes. If heterogeneity can be explained, we
will present the results of each subgroup separately (Furlan 2009).
Assessment of reporting biases
To minimize the risk of publication bias, we will search trial registry
databases for ongoing and unpublished trials.
Duplicate publication bias is related to use of the same patients’
data in multiple publications. To reduce the risk of bias, all such
studies should be combined and analysed as a single study. Moreover to avoid language reporting bias, no limitations of language
will be placed on the initial searches.
Data synthesis
If possible, the results will be pooled. We will calculate the risk
ratios (RRs) with a 95% confidence interval for dichotomous outcomes. If included studies show clinical and methodological diversity, the random-effects model will be applied. The Chi2 test
will be used to assess heterogeneity with results inferior to 0.1 indicating significant statistical difference.
If a meta-analysis is not possible, the results from clinically comparable trials will be described qualitatively in the text.
Regardless of whether there are sufficient data available to use
quantitative analysis to summarize the data, we will assess the overall quality of the evidence for each outcome. To accomplish this, we
will use the GRADE approach, as recommended in the Cochrane
Handbook for Systematic Reviews of interventions (Higgins 2011)
and adapted in the updated CBRG method guidelines (Furlan
2009). Factors that may decrease the quality of the evidence are:
study design and risk of bias, inconsistency of results, indirectness,
imprecision (sparse data) and other factors (e.g. reporting bias).
The quality of the evidence for a specific outcome will be reduced
by a level, according to the performance of the studies against these
five factors.
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High quality evidence: there are consistent findings among at
least 75% of RCTs with low risk of bias, consistent, direct and
precise data and no known or suspected publication biases. Further
research is unlikely to change either the estimate or our confidence
in the results.
Moderate quality evidence: one of the domains is not met. Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality evidence: two of the domains are not met. Further
research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality evidence: three of the domains are not met. We
are very uncertain about the results.
No evidence: no RCTs were identified that addressed this outcome.

Subgroup analysis and investigation of heterogeneity
We aim to perform subgroup analyses in order to explore heterogeneity due to the following factors:
1. Surgical technique applied, comparing different
laminoplasty techniques
2. Patient characteristics:
• Physiopathology of cervical stenosis (development,
degenerative, OPLL)
• Degree of neurological deficit
• Levels affected
• Age
• Sagittal alignment before surgical procedure

Sensitivity analysis
A sensitivity analysis will be performed to investigate the effects
of any important sources of bias.
A glossary of relevant terms can be found in Appendix 3.

’Summary of findings’ tables
The ’Summary of findings’ tables will include the main comparison of this review, laminectomy and fusion versus laminoplasty.
In order to assess the treatments we will report the following outcomes in each table:
1. Neurological function improvement;
2. Quality of life analysis;
3. Pain evaluation;
4. Cervical range of motion;
5. Kyphosis incidence;
6. C5 root palsy;
7. Reoperation rates.
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APPENDICES

Appendix 1. Search strategies

MEDLINE
1.
2.
3.
4.
5.
6.

randomized controlled trial.pt.
controlled clinical trial.pt.
pragmatic clinical trial.pt.
comparative study.pt.
randomi#ed.ti,ab.
placebo.ti,ab.
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7. drug therapy.fs.
8. randomly.ab,ti.
9. trial.ab,ti.
10. groups.ab.
11. exp Cohort Studies/
12. cohort$.ti,ab.
13. comparative$.ti,ab.
14. prospective$.ti,ab.
15. or/1-14
16. (animals not (humans and animals)).sh.
17. 15 not 16
18. (cervical adj5 myelopathy).ti,ab.
19. (cervical adj5 myeloradiculopathy).ti,ab.
20. (cervical adj5 radiculomyelopathy).ti,ab.
21. cervical vertebrae/
22. (cervical adj5 (compress$ or stenosis or herniat$ or degenerat$ or radicul$ or decompress$)).ti,ab.
23. longitudinal ligaments/
24. ossification of posterior longitudinal ligament/
25. ossification of posterior longitudinal ligament.ti,ab.
26. (cervical adj5 (lamin#plasty or laminectomy or laminotomy)).ti,ab.
27. spinal osteophytosis/
28. spinal cord compression/
29. spondylosis/
30. spinal diseases/
31. limit 30 to yr=1963-1965
32. or/18-29,31
33. laminectomy.mp.
34. lamin#plasty.mp.
35. laminectomy/
36. laminoplasty/
37. laminotomy.mp.
38. ((dorsal or poster$) adj5 (approach$ or surg$ or decompress$ or instrument$ or technique$)).mp. [mp=title, abstract, original
title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier]
39. decompression, surgical/
40. or/33-39
41. 17 and 32 and 40

Appendix 2. Criteria for assessing risk of bias for internal validity for randomized and nonrandomized studies (Furlan 2009; Downs and Black 1998)

I. Selection bias

Random sequence generation

Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence
There is a low risk of selection bias if the investigators describe a random component in the sequence generation process such as: referring
to a random number table, using a computer random number generator, coin tossing, shuffling cards or envelopes, throwing dice,
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drawing of lots, minimization (minimization may be implemented without a random element, and this is considered to be equivalent
to being random).
There is a high risk of selection bias if the investigators describe a non-random component in the sequence generation process, such
as: sequence generated by odd or even date of birth, date (or day) of admission, hospital or clinic record number; or allocation by
judgement of the clinician, preference of the participant, results of a laboratory test or a series of tests, or availability of the intervention.
For non-randomized studies (NRSs) this will be rated as ’high bias’ automatically.

Allocation concealment

Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment
There is a low risk of selection bias if the participants and investigators enroling participants could not foresee assignment because
one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web-based
and pharmacy-controlled randomization); sequentially numbered drug containers of identical appearance; or sequentially numbered,
opaque, sealed envelopes.
There is a high risk of bias if participants or investigators enroling participants could possibly foresee assignments and thus introduce
selection bias, such as allocation based on: using an open random allocation schedule (e.g. a list of random numbers); assignment
envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non-opaque or not sequentially numbered);
alternation or rotation; date of birth; case record number; or other explicitly unconcealed procedures.
In cases of NRSs this will be rated as high bias.

Population*

There is a low risk of bias if the participants included in different intervention groups are originating from the same population group.

Timing*

The risk of bias is considered low if the participants included in different intervention groups are recruited over the same time.

Adjustment for confounding*

There is a low risk of bias if there are no significant differences between the studied groups. Risk is considered high if there are no
investigation or final analyses adjustment of the main confounders identified.

II. Performance bias

Blinding of participants

There is a low risk of performance bias if blinding of participants was ensured and it was unlikely that the blinding could have been
broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced
by lack of blinding.

Blinding of personnel/care providers

There is a low risk of performance bias if blinding of personnel was ensured and it was unlikely that the blinding could have been
broken; or if there was no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced
by lack of blinding.
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Compliance (adherence)

There is low risk of bias if compliance with the interventions was acceptable, based on the reported intensity/dosage, duration, number
and frequency for both the index and control intervention(s). For single-session interventions (e.g. surgery), this item is irrelevant (van
Tulder 2003).

Co-interventions

There is low risk of bias if there were no co-interventions or they were similar between the index and control groups (van Tulder 2003).

III. Attrition bias

Incomplete outcome data

There is a low risk of attrition bias if there were no missing outcome data; reasons for missing outcome data were unlikely to be related
to the true outcome (for survival data, censoring unlikely to be introducing bias); missing outcome data were balanced in numbers,
with similar reasons for missing data across groups; for dichotomous outcome data, the proportion of missing outcomes compared
with the observed event risk was not enough to have a clinically relevant impact on the intervention effect estimate; for continuous
outcome data, the plausible effect size (difference in means or standardized difference in means) among missing outcomes was not
enough to have a clinically relevant impact on observed effect size, or missing data were imputed using appropriate methods (if dropouts are very large, imputation using even ’acceptable’ methods may still suggest a high risk of bias) (van Tulder 2003). The percentage
of withdrawals and drop-outs should not exceed 20% for short-term follow-up and 30% for long-term follow-up and should not lead
to substantial bias (these percentages are commonly used but arbitrary, not supported by literature) (van Tulder 2003).

Intention-to-treat analysis

There is low risk of bias if all randomized patients were reported/analyzed in the group to which they were allocated by randomization.

IV. Measurement/detection

Blinding of outcome assessment

There is low risk of bias if blinding of the outcome assessment was ensured and it was unlikely that the blinding could have been broken;
or if no blinding of incomplete blinding was performed, but the review authors judge that the outcome is not likely to be influenced
by lack of blinding, or:
• for participant-reported outcomes in which the participant was the outcome assessor (e.g. pain, disability): risk of bias for
outcome assessors is low if risk of bias for participant blinding is low;
• for outcome criteria that are clinical or therapeutic events that will be determined by the interaction between participants and
care providers (e.g. co-interventions, length of hospitalization, treatment failure), in which the care provider is the outcome assessor:
risk of bias for outcome assessors is low if risk of bias for care providers is low;
• for outcome criteria that are assessed from data from medical forms: risk of bias is low if the treatment or adverse effects of the
treatment could not be noticed in the extracted data.

Timing of outcome assessment

There is low risk of bias if all important outcome assessments for all intervention groups were measured at the same time (van Tulder
2003), or if analyses adjust for different lengths of follow-up.
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V. Selective reporting

Data dredging

There is low risk of bias if all analyses were planned at the outset of the study, and high risk of bias if analyses were conducted
retrospectively (e.g. retrospective unplanned subgroup analyses).

Outcome measures

There is low risk of reporting bias if the study protocol is available and all of the study’s pre-specified (primary and secondary) outcomes
that are of interest in the review have been reported in the pre-specified way, or if the study protocol is not available but it is clear that
the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be
uncommon).
There is a high risk of reporting bias if not all of the study’s pre-specified primary outcomes have been reported; one or more primary
outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified; one or
more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected
adverse effect); one or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a metaanalysis; the study report fails to include results for a key outcome that would be expected to have been reported for such a study.
* Items are relevant to non-randomized studies exclusively.

Appendix 3. Glossary
Articular facets: Facet joint. Portion that connects vertebrae of different levels.
Arthrodesis: Surgical procedure to achieve bone fusion.
Arthroplasty: Replacement of a joint by an artificial device with the function of maintaining movement.
Ataxia: Loss of muscular coordination as a result of damage to the central nervous system.
Axial section: Cross section.
C5 root palsy: Special type of paralysis that affects the 5th cervical nerve root. Can recover spontaneously.
Cervical: Neck, upper spine.
Corpectomy: Surgical procedure in which the vertebral body is removed.
Cortex: Peripheral portion of an organ (e.g. bone cortex, cerebral cortex).
Discectomy: Surgical procedure of intervertebral disc removal.
Dorsiflexion of the hallux: Movement in dorsal direction of big toe, lift the big toe.
Dysphagia: Difficulty swallowing.
Hyperreflexia: Exaggerated reflexes.
Hypertrophy: A non-tumorous enlargement of an organ or a tissue.
Interphalangeal: Between phalanges (fingers and toes).
Interspinous and supraspinous ligaments: Posterior ligaments of the spine. They help to stabilize the vertebrae.
Ipsilateral: Located on the same side of the body.
Kyphosis: Curvature of the spine with anterior convexity. Normal for middle spine, pathological for cervical (upper) or lumbar (low)
spine.
Lamina: Portion of posterior vertebra bone arch removed at laminectomy surgical procedure.
Lordosis: Curvature of the spine with posterior convexity. Normal for cervical (upper) and lumbar (low) spine.
Midsagittal: A plane dividing the human body in bilaterally symmetrical right and left halves.
Necrosis: Death of tissue due to injury or disease.
Ossification: Bone formation.
Pedicle: Bone structure responsible for connecting the vertebral body to posterior bone elements, also location of insertion of pedicle
screws.
Pedicle screw: Screw inserted into vertebral pedicle.
Phalanx: Bone segment that compose fingers and toes.
Plantar: Of, relating to, or occurring on the sole of the foot.
Radicular: Related to spinal roots.
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Spinal cord: The main neuronal structure that conducts the stimulus for movement from the brain to the limbs as well as conducts the
sensitive signals from the periphery to the brain.
Spinal process: Bony projection off the midline of posterior arch of each vertebra.
Spondylotic: Degenerative spinal change.
Upper motor neuron syndrome: Conjunct of symptoms associated with a lesion of motor neurons in the brain or spinal cord region.
Vascular: Of, relating to, affecting, or consisting of a vessel or vessels.
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